Find Academic Supervisors

Trond Vidar Hansen is a Professor at the Department of Pharmacy, University of Oslo , and leads the LIPCHEM research group . He collaborates with institutions including the University of Bergen and Vestlandets Innovasjonsselskap through the VITADEL project, which recently received NOK 5,000,000 in verification support from the Research Council of Norway. His research focuses on the synthesis and biological evaluation of specialized pro-resolving lipid mediators derived from omega-3 fatty acids, with applications in inflammation resolution, neuroinflammation, and drug development. University : University of Oslo Department : Department of Pharmacy Research Group : LIPCHEM Collaborations : University of Bergen, Vestlandets Innovasjonsselskap Research Interests : H Hansen's work centers on the organic synthesis of bioactive lipid derivatives, particularly pro-resolving mediators from omega-3 polyunsaturated fatty acids. His team investigates their roles in inflammatory disease models , neuroinflammation , and PPAR receptor activation , aiming to develop therapeutic agents for conditions like chronic pain, diabetes, and neurodegenerative disorders. The research integrates stereoselective chemistry , biochemical profiling , and pharmacological evaluation to validate these mediators' clinical potential. Recent Awards : 2025: NOK 2,000,000 verification support from Research Council of Norway 2025: Co-leader of NOK 5,000,000 VITADEL project Publications : His articles (2015–2024) reveal a focus on stereoselective synthesis of resolvins, protectins, and maresins, with applications in anti-inflammatory and neuroprotective therapies . Key subfields include omega-3 metabolite profiling , PPAR agonist design , and biosynthetic pathway elucidation , often utilizing human cell models and mouse disease models . Collaborative projects emphasize commercialization of academic research and translational medicine .

• Organic Chemistry
• Biochemistry
• Pharmacology
• +3 more

Silje C. Wangberg is a Professor of Public Health and serves as Vice Dean for Research Education and Practice for Nursing BSc and further education programs at UiT The Arctic University of Norway, Campus Narvik. She is a psychologist with a holistic perspective on health and disease, focusing on supporting individuals in taking the best possible care of themselves to live a good life with optimal physical, mental, emotional, social, and spiritual well-being. Her primary research interests include: eHealth and mHealth applications Health behavior and behavior change Health promotion and prevention Physical activity and smoking cessation Diabetes and heart disease management Social inequality in health Mindfulness, yoga, and meditation Dr. Wangberg's extensive publication record demonstrates consistent focus on digital health interventions, particularly examining how internet and mobile technologies can support health behavior change across various populations. Her recent work shows increasing emphasis on specialized populations including individuals with intellectual disabilities and exploration of emerging technologies like augmented reality in healthcare education. She maintains a strong interest in addressing health inequalities through technological solutions while recognizing the continued importance of human factors in health management. She is an active member of the HEL research group focused on Public Health and Rehabilitation, and participates in the One Health project at Campus Narvik.

• Public Health
• eHealth
• mHealth
• +12 more

Bjørn Olav Åsvold, MD, PhD, is a Professor of Medicine (Epidemiology) and Center leader at the HUNT Centre for Molecular and Clinical Epidemiology (HUNT MCE), Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU). He also serves as a Consultant at the Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital. His research spans epidemiology, genetics, and clinical medicine. MD, Norwegian University of Science and Technology, 2001 PhD, Norwegian University of Science and Technology, 2008 Specialist in internal medicine, 2014 Specialist in endocrinology, 2015 Åsvold's research focuses on thyroid dysfunction and diabetes , investigating their interplay with cardiometabolic diseases and pregnancy complications . He utilizes Mendelian randomization studies to explore causal relationships between genetic factors and health outcomes, including sleep traits , autoimmune thyroid disease , and kidney function . His work also addresses global health issues like obesity in Nepal and diabetic complications in Norway. Recent publications highlight his contributions to understanding hip fracture risk prediction , cardiovascular implications of sleep patterns , and genetic determinants of trace elements . Åsvold's collaborations span multiple international institutions, including the HUNT Study and HUNT MCE in Norway.

• Thyroid dysfunction
• Diabetes
• Pregnancy complications and cardiovascular risk
• +1 more

Joao Carlos Amaro Ferreira is a Professor at the Faculty of Logistics, Molde University College (HiMolde), Norway. He holds PhDs in Computer Engineering and Industrial Engineering from the Technical University of Lisbon and the University of Minho, respectively. His research focuses on Artificial Intelligence (AI) applications in healthcare, energy, transportation, IoT, blockchain, and smart cities. He has led over 40 projects, including 6 as Principal Investigator, and contributed to international conferences like OAIR and INTSYS. He served as IEEE CIS President (2016-2018) and is an IEEE Senior Member since 2015. His academic contributions span AI-driven solutions for public sector informatics, healthcare data quality, and cybersecurity. He actively participates in European projects such as e-Hospital4Future and explores blockchain applications in supply chains and medical records. Ferreira leads the ABC-AI research group, emphasizing ethical and applied AI. His work bridges academia and industry through projects like gamification systems for eco-driving and AI in fisheries traceability. Recent publications highlight AI's role in cardiovascular disease detection, emergency department optimization, and blockchain-enhanced healthcare interoperability. He collaborates internationally, co-editing journals like Applied Sciences , and has authored patents in edge computing for maritime monitoring.

• Artificial Intelligence
• AI in Health and Medicine
• AI in Energy and Transportation
• +6 more

Sebastien Nicolas Gros is a Professor at the Department of Engineering Cybernetics, Norwegian University of Science and Technology (NTNU). His research focuses on safe reinforcement learning (RL) and data-driven model predictive control (MPC), with applications in energy systems, biomedical engineering, and autonomous vehicles. Institution: Norwegian University of Science and Technology Department: Engineering Cybernetics His work emphasizes AI-driven optimization for domestic energy storage, battery integration, and smart building management. Collaborations include Equinor, DNV, Kongsberg, Volvo, and CorPower Ocean. Key themes in his publications include: Control theory for renewable energy systems (wave energy converters, buildings) Biomedical applications (artificial pancreas, glucose monitoring) Transportation systems (electric vehicles, autonomous ships) Machine learning integration with physical models He supervises 6 PhD students and co-supervises projects on multi-rotor wind turbines and industrial PhD collaborations. The articles demonstrate a convergence of RL, MPC, and uncertainty quantification across energy, biomedical, and transportation domains.

• Safe Reinforcement Learning
• Data-Driven Model Predictive Control
• Artificial Intelligence
• +7 more

Tor Iversen is a Professor of Health Economics at the University of Oslo, affiliated with the Department of Health Management and Health Economics within the Institute of Health and Society. He holds a Ph.D. in Economics (1993) and a cand. oecon. (1978) from the University of Oslo. His research focuses on market conditions in healthcare, economic incentives for healthcare providers, and policy evaluations such as free choice reforms and primary care team models. Education: Doctorate in Economics (1993), University of Oslo; cand. oecon. (1978), University of Oslo. Research Interests: Non-price rationing mechanisms in healthcare, economic incentives in long-term care, digital surveillance for chronic disease management, and cross-country comparisons of treatment outcomes and costs. Current projects include evaluations of Norway’s primary healthcare teams pilot program, telemedicine interventions for chronic conditions, and cost-effectiveness analyses of healthcare policies. Professional Activities: Iversen has held editorial roles at the International Journal of Health Care Finance and Economics and the Nordic Journal of Health Economics . He collaborates with institutions globally, including Karolinska Institutet, Harvard University, and the University of Melbourne. His research emphasizes healthcare access, provider behavior, and policy impacts. Grants/Advising: Led evaluations of healthcare reforms and pilot programs, including the Norwegian Primary Healthcare Teams project. His work often involves interdisciplinary teams and practical policy applications. Labs/Teams: Part of the Health Economics Research Programme (HERO) and contributed to initiatives like NORCHER (Norwegian Centre for Health Services Research) and the OMIT cohort study on diabetes outcomes.

• Health Economics
• Health Policy
• Healthcare Management
• +5 more

Ragnheidur Bragadottir is a Professor in the Department of Ophthalmology at the University of Oslo, affiliated with Oslo University Hospital (OUS Ullevål). Her primary affiliation is within the Faculty of Medicine. She specializes in retinal diseases, vitreoretinal surgery, and inherited retinal disorders, with a focus on clinical electrophysiology and gene therapy applications. Her research addresses genetic syndromes like Bardet-Biedl syndrome, ABCA4-related dystrophies, and Stargardt disease, emphasizing translational medicine and patient-centered care. Her work spans clinical trials evaluating anti-VEGF therapies, surgical innovations (e.g., intraoperative OCT for macular holes), and long-term outcomes of treatments like phacovitrectomy. She collaborates extensively on consensus statements (e.g., MHOST for macular hole management) and investigates the burden of chronic retinal diseases on patients and healthcare systems. Bragadottir’s contributions also include foundational studies on gene therapy in RPE65-deficient models and optical imaging advancements for retinal biomarker analysis. Publications highlight her expertise in retinal degeneration mechanisms, surgical techniques, and drug efficacy comparisons (e.g., aflibercept vs. bevacizumab). She is actively involved in the Clinical Retinal Research group and the Center for Eye Research, driving both basic science and clinical ophthalmology advancements.

• Ophthalmology
• Retinal Diseases
• Vitreoretinal Surgery
• +3 more

Miriam K. Gustafsson serves as Associate Professor in the Department of Public Health and Nursing at the Norwegian University of Science and Technology (NTNU), with active research and teaching responsibilities. Her institutional affiliation includes the Samfunnsmedisinbygget facility in Øya, Trondheim. Her educational background includes an MD from Lund University, Sweden (1998), followed by PhD studies in the Department of Public Health and Nursing at NTNU from 2013-2018. Her doctoral dissertation focused on Vitamin D status and health-related quality of life in pregnancy-impact of exercise . Gustafsson's research centers on maternal-fetal nutrition, particularly vitamin D metabolism during pregnancy and its long-term impacts on offspring health. Her work spans nutritional epidemiology, obesity research, and diabetes prevention, with significant contributions to understanding how prenatal vitamin status affects childhood bone development, dental health, and metabolic outcomes. Recent studies extend into Nepalese population health, examining obesity and diabetes prevalence in rural communities. Analysis of her publication trajectory reveals consistent focus on vitamin D's role in pregnancy since 2016, evolving from Norwegian cohort studies to international comparative research. Her work demonstrates methodological diversity across randomized controlled trials, longitudinal cohort analyses, and population-based surveys, with increasing emphasis on interdisciplinary approaches to maternal-child health. As an academic advisor, she has supervised Master's theses including Axel Sjilov's Should we be concerned about the vitamin A status among Norwegian pregnant women? (2020) and Klara Evjen Seim's The Association Between Maternal Vitamin D Status and Bone Mass in Offspring at 8-9 Years of Age (2018). Her outreach activities include developing the BEDre interdisciplinary obesity treatment model and regular public health communication through media interviews. Gustafsson actively participates in research teams including the longitudinal pregnancy cohort study tracking maternal vitamin status and child outcomes, and collaborates with dental health researchers on enamel hypomineralization projects. Her recent outreach includes academic lectures at European Calcified Tissue Society meetings and popular science presentations on eating disorders through ROS Trøndelag.

• Maternal and Child Health
• Nutritional Epidemiology
• Vitamin D Metabolism
• +4 more

Cathrine Arntzen is a Professor at the Department of Health and Care Sciences, UiT The Arctic University of Norway, and Academic Director at the Center for Care Research North. Her work spans health services research, occupational therapy, and rehabilitation within municipal healthcare systems. She contributes to projects like RehabLos and engages in co-design methodologies. Affiliation: UiT The Arctic University of Norway Directorship: Center for Care Research North Research: Rehabilitation, occupational therapy, e-health, and service co-design Her research focuses on person-centered rehabilitation, service coordination across sectors, and digital health systems. She explores user involvement, organizational factors in care delivery, and innovative models for chronic disease management, particularly in rural contexts. Recent publications address unplanned hospital admissions among elderly, digital rehabilitation tools, stroke recovery, and supported employment integration. She employs qualitative methods, mixed-method designs, and action research to analyze healthcare challenges in Northern Norway. Arntzen collaborates with multidisciplinary teams on projects such as RehabLos, which emphasizes community-based rehabilitation models for individuals with acquired brain injuries. Her work bridges academic research with municipal healthcare practice.

• Health Services Research
• Occupational Therapy
• Rehabilitation
• +12 more

Ivana Bojanic is a full-time Researcher at the Faculty of Nursing and Health Sciences, Nord University, Norway. She holds a PhD in Medicine and Health Sciences from NTNU (2023) and has a background in pharmacy, medical biochemistry, and clinical experience as a laboratory head in Serbia. Her research focuses on mental health, drug use patterns, and cultural safety in healthcare, particularly among the Sami population and Arctic indigenous communities. She leads interdisciplinary projects funded by organizations like NordForsk and SANKS, addressing mental health in cardiovascular diseases/diabetes, digital health innovations for aging populations, and culturally safe healthcare services. Education: BSc in Pharmacy and Medical Biochemistry from the University of Belgrade, MSc in Pharmaceutical Health Prevention (University of Belgrade), PhD in Medicine and Health Sciences (NTNU). Teaching responsibilities include physiology, pharmacology, and quantitative research methods at bachelor's and master's levels. She supervises PhD and master's students and collaborates internationally on public health initiatives. Key Research Projects include: "Exploring Cultural Safety in Municipal Healthcare Services for Saami with Somatic Diseases" (Project Manager, NOK 267,000) "Promoting Healthy Aging of Sámi and Inuit Elders Through Co-Designed Digital Health Tool" (NordForsk, NOK 15 million) She is affiliated with research groups: Healthcare and Population Health, Pharmaceuticals and Pharmaceutical Management. Her work emphasizes co-design methods, quantitative/qualitative research, and health equity for marginalized groups such as the Sami population.

• Epidemiology
• Drug Use
• Mental Health
• +6 more

Hege Christensen is a Professor of Pharmacology at the University of Oslo's Department of Pharmaceutical Biosciences. She has been affiliated with the Department since 1992 and holds leadership roles in academic programs such as the Master's Degree in Pharmacy and Clinical Pharmacy. Her research focuses on pharmacokinetics, particularly drug metabolism variability due to genetic and environmental factors, and drug interactions. She collaborates with institutions like the IMUP Center for Immunopharmacology in Transplantation and the School of Pharmacy at the University of Manchester. Key areas include physiology-based pharmacokinetic modeling and in vitro-in vivo extrapolation techniques. Christensen's education includes a Cand.pharm. from the University of Oslo (1986), a Dr.scient. (1992), and an Advanced Diploma in Clinical Pharmacy Teaching from the University of Leeds (1996). Her career spans roles at the International Heart Research Institute (1991–1992) and pharmaceutical industries like Løvens Kemiske Fabrik (1986–1987). Her research interests emphasize understanding drug bioavailability and optimizing therapies through pharmacokinetic studies. Recent work investigates gastric bypass surgery's effects on drug metabolism and the role of microbiome signatures in weight loss outcomes. She has published extensively in journals like Clinical Pharmacokinetics and Mucosal Immunology, with a focus on cytochrome P450 enzymes, drug transporters, and obesity-related pharmacology. Notable collaborations include projects with Professor Amin Rostami-Hodjegan at the University of Manchester, exploring advanced pharmacokinetic modeling. Her work bridges clinical and translational research, addressing challenges in drug dosing for patients with obesity and comorbidities.

• Pharmacokinetics
• Drug metabolism
• Drug transport
• +3 more

Martin Wulf Gerdes is an Associate Professor at the Department of Information and Communication Technology, University of Agder, Norway. With a Ph.D. in eHealth and over two decades of experience in telecommunications and healthcare technology research, he focuses on developing user-friendly, interoperable eHealth solutions using ICT and IoT. His career spans roles at Ericsson Eurolab and academic leadership in Norway. Education: M.Sc. equivalent in General Electrical Engineering (1998) from RWTH Aachen, emphasizing ICT. Ph.D.: Information and Communication Technologies with eHealth specialization (2019) from University of Agder. Research Interests: Gerdes explores AI-driven decision support systems, distributed eHealth infrastructure, telemedicine, and assistive technologies for chronic disease management. His work bridges IoT, data privacy, and user-centered design in healthcare robotics. Teaching: Since 2014, he has taught at bachelor's and master's levels, currently leading courses in Communication & Cooperation, Technology Understanding, and seminar projects in eHealth. Scientific Publications: His 15 most recent articles (2020-2024) span AI in dental radiology, blood glucose prediction, digital twins, and ethical considerations in healthcare algorithms. Topics include IoT integration, data privacy, and pandemic analytics.

• eHealth
• Artificial Intelligence
• Machine Learning
• +9 more

Henrik Berg is Professor at the Institute of Psychosocial Health, University of Agder, specializing in philosophical and ethical critiques of evidence-based practice in psychology. His interdisciplinary research examines the intersection of clinical psychology, medical ethics, and philosophy of science. Research focuses include: Epistemological foundations of evidence-based practice Ethical frameworks in psychotherapy Philosophical analysis of clinical decision-making Critical studies of healthcare systems and guidelines Publication analysis reveals consistent themes across 15+ works: rigorous critique of scientocentrism in psychology, exploration of virtue ethics in clinical practice, and systematic investigations into healthcare inequities. Recent works increasingly address epistemic injustice in medical contexts. No information regarding research grants, student advising, or laboratory affiliations is provided in source materials.

• Evidence-Based Practice
• Psychotherapy Ethics
• Philosophy of Psychology

Kine Pedersen is an Associate Professor at the Department of Health Management and Health Economics within the Faculty of Medicine at the University of Oslo. Her academic career focuses on health economic analysis, disease simulation modeling, and evaluation of healthcare interventions with particular expertise in cervical cancer prevention, HPV-related disease control, and primary care services. She has established herself as a leading researcher in cost-effectiveness analysis of preventive healthcare strategies within the Norwegian healthcare system. Education: PhD in Health Economics and Health Policy, University of Oslo (2018) M.Phil. in Health Economics, Policy and Management, University of Oslo (2014) BA in Economics, University of Oslo (2012) BA in Health Management and Health Economics, University of Oslo (2011) Dr. Pedersen's research program centers on developing and applying sophisticated mathematical models to evaluate preventive healthcare interventions, with a strong emphasis on cervical cancer screening programs and HPV vaccination strategies. Her work bridges health economics, epidemiology, and clinical practice to inform evidence-based healthcare policy. She has made significant contributions to understanding how to optimize screening protocols for vaccinated versus unvaccinated populations and has extensively studied the cost-effectiveness of various approaches to accelerate cervical cancer elimination in Norway. Her recent publications (2022-2024) reveal an expanding research portfolio that now includes telemedicine applications for chronic disease management and team-based primary care models, while maintaining her core focus on cancer prevention. The consistent thread through her work is the application of rigorous health economic methodologies to evaluate preventive interventions, with particular attention to structural uncertainty in modeling and real-world implementation challenges. Scientific Awards: The Society for Medical Decision Making's Lee B. Lusted Student Prize in Health Services and Policy Research Dr. Pedersen teaches HEVAL5120: Modelling in Economic Evaluation I and HMET4210: Research Design. Her research is supported through collaborations with the Cancer Registry of Norway, Center for Health Decision Science at Harvard T.H. Chan School of Public Health, Norwegian Institute of Public Health, and Department of Biostatistics at Aarhus University. She leads or participates in several significant research projects including ASCERTAIN, Optimal Cervical Cancer Prevention Policies (CC-PREVENT), and EXCEED – Network for economic evaluation in Norway. Her work directly informs Norwegian healthcare policy and contributes to international efforts to eliminate cervical cancer through evidence-based preventive strategies.

• Health Economic Analysis
• Disease Simulation Modeling
• Cervical Cancer Prevention
• +5 more

Anders Åsberg is a Professor at the Department of Pharmacy, University of Oslo, with a focus on pharmacokinetics and its application in organ transplant recipients. He leads the Section of Pharmacology and Pharmaceutical Biosciences and is actively involved in clinical studies related to immunosuppressive drug therapy. Current affiliation: Professor II, University of Oslo Previous roles: Managing Director, Renal Physiology Laboratory (2013–present); Medical Director, Roche Norge AS (2000–2003) Research Interests : Pharmacokinetics of immunosuppressive drugs Drug interactions in transplantation Role of transporters in drug disposition Population modeling for therapeutic drug monitoring Clinical trials in transplant recipients Effects of metabolic changes (e.g., gastric bypass) on drug metabolism Scientific Awards : Best Young Investigator, European Renal Association (2001) Collaborations span institutions such as the Clinical Pharmacokinetic Research Laboratory at the University of Rhode Island and the Laboratory of Applied Pharmacokinetics at the University of Southern California. His work frequently addresses the interplay between drug therapy, patient physiology, and long-term outcomes in kidney transplantation.

• Pharmacokinetics
• Transplantation
• Immunosuppressive Drugs
• +6 more